Theleme Partners LLP is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q4 2025, the fund manages $1.5B in reported equity holdings across 9 positions. The largest holdings are META (18.5%), MRNA (15.5%), FLUT (12.5%), TRU (12.5%), WFC (12.0%). The portfolio is concentrated in Other (81.5%), Communication Services (18.5%). Data sourced from SEC EDGAR 13F filings (CIK 1511881).